IPO registrations (S-1, F-1) · Registrants
Medicus Pharma Ltd.
- SEC CIK
- 1997296 · filings on EDGAR ↗
- Registration
- Form F-1, S-1, first filed 2024-05-29, last 2025-11-19; 6 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2024-11-15; declared effective 2024-11-13
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- A6
- Business address
- 300 CONSHOHOCKEN STATE RD., SUITE 200, W. Conshohocken, PA 19428
- EIN
- 98-1778211
- Ticker
- MDCX, MDCXW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Medicus Pharma Ltd. on the corporate pages
Offering terms
- Final price
- $4.64 per share (424B4 filed 2024-11-15, an initial public offering)
- Shares sold
- 970,000
- Gross proceeds
- $4,500,800 before underwriting discounts and any over-allotment option
- Listing
- TSX under the symbol MDCX
- Lead underwriters
- Maxim Group
- Syndicate
- Brookline Capital Markets
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Medicus Pharma, Inc. Fuzzy (name and state)
- Form D issuer: Medicus Pharma Ltd. EXACT (CIK (EXACT))
- SEC filer: Medicus Pharma Ltd. EXACT (CIK (EXACT))
Filings 29
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-05-29 | F-1 | F-1 (foreign registration) | Medicus Pharma Ltd. | 0001062993-24-011392 ↗ |
| 2024-07-15 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-013814 ↗ |
| 2024-08-09 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-014789 ↗ |
| 2024-08-23 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-015601 ↗ |
| 2024-09-23 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-016893 ↗ |
| 2024-09-26 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-017000 ↗ |
| 2024-10-01 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-017093 ↗ |
| 2024-10-15 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-017676 ↗ |
| 2024-10-29 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-018057 ↗ |
| 2024-10-31 | F-1/A | F-1/A (amendment) | Medicus Pharma Ltd. | 0001062993-24-018174 ↗ |
| 2024-11-13 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-24-003472 ↗ |
| 2024-11-15 | 424B4 | 424B4 (final prospectus) | Medicus Pharma Ltd. | 0001062993-24-019175 ↗ |
| 2025-04-10 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-25-001062 ↗ |
| 2025-05-27 | S-1 | S-1 (registration) | Medicus Pharma Ltd. | 0001062993-25-010333 ↗ |
| 2025-05-27 | S-1 | S-1 (registration) | Medicus Pharma Ltd. | 0001062993-25-010394 ↗ |
| 2025-05-29 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-25-001778 ↗ |
| 2025-05-29 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-25-001780 ↗ |
| 2025-05-30 | 424B4 | 424B4 (final prospectus) | Medicus Pharma Ltd. | 0001062993-25-010548 ↗ |
| 2025-09-29 | S-1 | S-1 (registration) | Medicus Pharma Ltd. | 0001062993-25-015839 ↗ |
| 2025-09-29 | S-1 | S-1 (registration) | Medicus Pharma Ltd. | 0001062993-25-015841 ↗ |
| 2025-11-14 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-25-003291 ↗ |
| 2025-11-14 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-25-003292 ↗ |
| 2025-11-19 | S-1 | S-1 (registration) | Medicus Pharma Ltd. | 0001062993-25-016962 ↗ |
| 2025-12-04 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-25-003544 ↗ |
| 2025-12-31 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-26-000026 ↗ |
| 2026-02-04 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-26-000448 ↗ |
| 2026-03-27 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-26-000959 ↗ |
| 2026-03-27 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-26-000960 ↗ |
| 2026-03-27 | EFFECT | EFFECT (declared effective) | Medicus Pharma Ltd. | 9999999995-26-000961 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-31 | F-1/A | registration statement | 880,000 | - | TSX MDCX | 2 | primary document; shares headline, cover names 2 | document ↗ | ||
| 2024-11-15 | 424B4 | final prospectus | $4.64 | 970,000 | $4,500,800 | TSX MDCX | 2 | primary document; price line, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| 215 Capital TOGO PHL Fund I, LP | TenPercentOwner | 1 | 2024 | ||
| Ashton William | Director | 6 | 2024–2026 | ||
| Bokhari Raza | Director,Officer | Chief Executive Officer | 7 | 2024–2026 | |
| Bonner Carolyn F. | Officer | President; President and CFO | 6 | 2024–2026 | |
| Brennan Edward J. | Officer | Chief Scientific Officer | 6 | 2024–2026 | |
| Ciaruffoli Robert J. | Director | 6 | 2024–2026 | ||
| FISHMAN BARRY | Director | 6 | 2024–2026 | ||
| Kaiser Larry | Director | 6 | 2024–2026 | ||
| Lavelle Frank W | Director | 2 | 2024–2025 | ||
| May Sara R. | Director | 6 | 2024–2026 | ||
| Mehmud Faisal | Officer | Chief Medical Officer | 7 | 2024–2026 | |
| Melani Kenneth R. | TenPercentOwner | 3 | 2024–2025 | ||
| Quinlan James P. | Officer | Chief Financial Officer | 3 | 2024–2025 | |
| Raju Ajay | Director; Director,TenPercentOwner; TenPercentOwner | 5 | 2024–2026 | ||
| Togo PHL Management LLC | TenPercentOwner | 1 | 2024 | ||
| VELOCITY FUND PARTNERS, LP | TenPercentOwner | 2 | 2025 | ||
| Smith Andrew Alasdair | Officer | Chief Operating Officer | 6 | 2025–2026 | |
| Rodgers Cathy McMorris | Director | 4 | 2025–2026 | ||
| MAHAFFY PATRICK J | Director | 4 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-06-18 | Medicus Pharma Ltd. | Other Health Care | $11,017,500 | $11,017,500 | 23 | 2 |
| 2023-10-13 | Medicus Pharma Ltd. | Other Health Care | $4,926,950 | $4,926,950 | 68 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Medicus Pharma, Inc. | PA | State business registries | name and state |
| Plan sponsor | MEDICUS PHARMA, INC. | PA | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | Medicus Pharma Ltd. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Medicus Pharma Ltd. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- INOVIO PHARMACEUTICALS, INC. PA
- ADOLOR CORP PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- Vitae Pharmaceuticals, Inc PA
- PhaseBio Pharmaceuticals Inc PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health